Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer

PURPOSE: Two studies in previously-treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monocytogenes e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N., Sugar, Elizabeth, Wu, Annie A., Onners, Beth, Nauroth, Julie M., Anders, Robert A., Fertig, Elana J., Laheru, Daniel A., Reiss, Kim A., Vonderheide, Robert H., Ko, Andrew H., Tempero, Margaret A., Fisher, George A., Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G., Coussens, Lisa M., Jaffee, Elizabeth M., Le, Dung T.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727397/
https://ncbi.nlm.nih.gov/pubmed/32273276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3978
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki